Literature DB >> 29217155

Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model.

Kerstin K Landrock1, Patti Sullivan2, Heidi Martini-Stoica3, David S Goldstein4, Brett H Graham5, Shinya Yamamoto6, Hugo J Bellen7, Richard A Gibbs8, Rui Chen9, Marcello D'Amelio10, George Stoica11.   

Abstract

In this study, we analyze the neuropathological and biochemical alterations involved in the pathogenesis of a neurodegenerative/movement disorder during different developmental stages in juvenile rats with a mutant Myosin5a (Myo5a). In mutant rats, a spontaneous autosomal recessive mutation characterized by the absence of Myo5a protein expression in the brain is associated with a syndrome of locomotor dysfunction, altered coat color, and neuroendocrine abnormalities. Myo5a encodes a myosin motor protein required for transport and proper distribution of subcellular organelles in somatodendritic processes in neurons. Here we report marked hyperphosphorylation of alpha-synuclein and tau, as well as region-specific buildup of the autotoxic dopamine metabolite, 3,4-dihydroxyphenyl-acetaldehyde (DOPAL), related to decreased aldehyde dehydrogenases activity and neurodegeneration in mutant rats. Alpha-synuclein accumulation in mitochondria of dopaminergic neurons is associated with impaired enzymatic respiratory complex I and IV activity. The behavioral and biochemical lesions progress after 15 days postnatal, and by 30-40 days the animals must be euthanized because of neurological impairment. Based on the obtained results, we propose a pleiotropic pathogenesis that links the Myo5a gene mutation to deficient neuronal development and progressive neurodegeneration. This potential model of a neurodevelopmental disorder with neurodegeneration and motor deficits may provide further insight into molecular motors and their associated proteins responsible for altered neurogenesis and neuronal disease pathogenesis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Dopamine metabolism alteration; Dying back neurodegeneration; Mitochondria complex I-IV; Myo5a mutation; TEM; α-synuclein/tau-P

Mesh:

Substances:

Year:  2017        PMID: 29217155      PMCID: PMC7696654          DOI: 10.1016/j.brainres.2017.11.029

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  53 in total

1.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.

Authors:  G Ménasché; E Pastural; J Feldmann; S Certain; F Ersoy; S Dupuis; N Wulffraat; D Bianchi; A Fischer; F Le Deist; G de Saint Basile
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

Review 2.  Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.

Authors:  James E Galvin
Journal:  Acta Neuropathol       Date:  2006-06-22       Impact factor: 17.088

3.  Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.

Authors:  William J Burke; Vijaya B Kumar; Neeraj Pandey; W Michael Panneton; Qi Gan; Mark W Franko; Mark O'Dell; Shu Wen Li; Yi Pan; Hyung D Chung; James E Galvin
Journal:  Acta Neuropathol       Date:  2007-10-27       Impact factor: 17.088

4.  Molecular analysis of two mouse dilute locus deletion mutations: spontaneous dilute lethal20J and radiation-induced dilute prenatal lethal Aa2 alleles.

Authors:  M C Strobel; P K Seperack; N G Copeland; N A Jenkins
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

5.  Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin.

Authors:  Inmaculada Cuchillo-Ibanez; Anjan Seereeram; Helen L Byers; Kit-Yi Leung; Malcolm A Ward; Brian H Anderton; Diane P Hanger
Journal:  FASEB J       Date:  2008-05-29       Impact factor: 5.191

6.  alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.

Authors:  P H Jensen; H Hager; M S Nielsen; P Hojrup; J Gliemann; R Jakes
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

7.  Whole-genome SNP association in the horse: identification of a deletion in myosin Va responsible for Lavender Foal Syndrome.

Authors:  Samantha A Brooks; Nicole Gabreski; Donald Miller; Abra Brisbin; Helen E Brown; Cassandra Streeter; Jason Mezey; Deborah Cook; Douglas F Antczak
Journal:  PLoS Genet       Date:  2010-04-15       Impact factor: 5.917

Review 8.  Autophagy and neuronal cell death in neurological disorders.

Authors:  Ralph A Nixon; Dun-Sheng Yang
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

9.  Inherited tertiary hypothyroidism in Sprague-Dawley rats.

Authors:  George Stoica; Gina Lungu; Xueyi Xie; Louise C Abbott; Heidi M Stoica; John T Jaques
Journal:  Brain Res       Date:  2007-02-27       Impact factor: 3.252

10.  Novel myosin heavy chain encoded by murine dilute coat colour locus.

Authors:  J A Mercer; P K Seperack; M C Strobel; N G Copeland; N A Jenkins
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

View more
  8 in total

1.  Do indices of baroreflex failure and peripheral noradrenergic deficiency predict the magnitude of orthostatic hypotension in Lewy body diseases?

Authors:  Guillaume Lamotte; Makoto Takahashi; Tianxia Wu; Patricia Sullivan; Jamie Cherup; Courtney Holmes; David S Goldstein
Journal:  Clin Auton Res       Date:  2021-03-12       Impact factor: 4.435

2.  Myosin 5a in the Urinary Bladder: Localization, Splice Variant Expression, and Functional Role in Neurotransmission.

Authors:  Josephine A Carew; Vivian Cristofaro; Suhas P Dasari; Sean Carey; Raj K Goyal; Maryrose P Sullivan
Journal:  Front Physiol       Date:  2022-07-01       Impact factor: 4.755

3.  Sex-Specific Alterations in Dopamine Metabolism in the Brain after Methamphetamine Self-Administration.

Authors:  Atul P Daiwile; Patricia Sullivan; Subramaniam Jayanthi; David S Goldstein; Jean Lud Cadet
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

Review 4.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

5.  Myosin Va interacts with the exosomal protein spermine synthase.

Authors:  Luciano G Dolce; Rui M P Silva-Junior; Leandro H P Assis; Andrey F Z Nascimento; Jackeline S Araujo; Ingrid P Meschede; Enilza M Espreafico; Priscila O de Giuseppe; Mário T Murakami
Journal:  Biosci Rep       Date:  2019-03-01       Impact factor: 3.840

6.  CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer's and Parkinson's Disease.

Authors:  Rohan Gupta; Pravir Kumar
Journal:  ACS Omega       Date:  2021-12-16

7.  The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease.

Authors:  Regev Landau; Reut Halperin; Patti Sullivan; Zion Zibly; Avshalom Leibowitz; David S Goldstein; Yehonatan Sharabi
Journal:  Dis Model Mech       Date:  2022-01-24       Impact factor: 5.758

8.  Biochemical Neuroadaptations in the Rat Striatal Dopaminergic System after Prolonged Exposure to Methamphetamine Self-Administration.

Authors:  Subramaniam Jayanthi; Bruce Ladenheim; Patricia Sullivan; Michael T McCoy; Irina N Krasnova; David S Goldstein; Jean Lud Cadet
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.